Invexans S.A. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 1,162.09 million compared to USD 793.97 million a year ago. Net income was USD 26.16 million compared to USD 20.26 million a year ago. Basic earnings per share from continuing operations was USD 0.0005 compared to USD 0.0003 a year ago. Diluted earnings per share from continuing operations was USD 0.0005 compared to USD 0.0003 a year ago.